Logo image
Se connecter
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
Article de revue   Avec comité de lecture

Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients

Sarah Burkill, Celeste M Porsbjerg, Arnaud Bourdin, Trung N Tran, Neil Martin, Rohit Katial, Peter Barker, Michael E Wechsler, Jorge F Maspero, Sinthia Bosnic-Anticevich, …
01/12/2022

Résumé

R Medicine
Funding: This study was conducted by the Observational and Pragmatic Research Institute (OPRI) Pte Ltd and was partially funded by Optimum Patient Care Global and AstraZeneca Ltd. No funding was received by OPRI for its contribution. Peer reviewed

Indicateurs

1 Consultations de la notice

Détails

Logo image